Anthony A. Hyman
Founder at Dewpoint Therapeutics, Inc.
Profile
Anthony A.
Hyman is the founder of Cenix BioScience GmbH, which was founded in 1999.
He held the title of Gründer from 1999 to 2009.
He is also the founder of Dewpoint Therapeutics, Inc., which was founded in 2018.
Currently, Dr. Hyman is a Member-Governing Board at the Research Centre of Excellence in Mechanobiology.
In the past, he worked as a Director at the Max-Planck-Institute for Molecular Genetics.
Additionally, he held the position of Principal at The European Molecular Biology Laboratory from 1993 to 1998.
Dr. Hyman obtained his doctorate degree from the University of Cambridge in 1988.
Anthony A. Hyman active positions
Companies | Position | Start |
---|---|---|
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Founder | 01/08/2018 |
Research Centre of Excellence in Mechanobiology
Research Centre of Excellence in Mechanobiology Miscellaneous Commercial ServicesCommercial Services The Research Centre of Excellence in Mechanobiology conducts research and development in the field of life and biological sciences. The private company is based in Singapore, Singapore. The Singaporean company was founded in [year] by Paul Matsudaira and Michael Sheetz. | Director/Board Member | - |
Former positions of Anthony A. Hyman
Companies | Position | End |
---|---|---|
The European Molecular Biology Laboratory | Corporate Officer/Principal | 02/01/1998 |
Max-Planck-Institute for Molecular Genetics | Director/Board Member | - |
Cenix BioScience GmbH
Cenix BioScience GmbH Miscellaneous Commercial ServicesCommercial Services Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide | Founder | - |
Training of Anthony A. Hyman
University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Cenix BioScience GmbH
Cenix BioScience GmbH Miscellaneous Commercial ServicesCommercial Services Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide | Commercial Services |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Health Technology |
Research Centre of Excellence in Mechanobiology
Research Centre of Excellence in Mechanobiology Miscellaneous Commercial ServicesCommercial Services The Research Centre of Excellence in Mechanobiology conducts research and development in the field of life and biological sciences. The private company is based in Singapore, Singapore. The Singaporean company was founded in [year] by Paul Matsudaira and Michael Sheetz. | Commercial Services |
- Stock Market
- Insiders
- Anthony A. Hyman